D. Markovitz - Engineering a therapeutic Lectin: uncoupling mitogenicity from antiviral activity

David Markovitz, Department of Internal Medicine, University of Michigan, Michigan, MI, USA speaks on "Engineering a therapeutic Lectin: uncoupling mitogenicity from antiviral activity". This seminar has been recorded by ICGEB Trieste.

Om Podcasten

Looking at the basic biology of diseases that are caused by pathogenic microorganisms and possible therapies.